Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma
To recognize the epidermal growth factor receptor (EGFR) gene mutation status in lung adenocarcinoma (LADC) has become a prerequisite of deciding whether EGFR-tyrosine kinase inhibitor (EGFR-TKI) medicine can be used. Polymerase chain reaction assay or gene sequencing is for measuring EGFR status, h...
Main Authors: | Baihua Zhang, Shouliang Qi, Xiaohuan Pan, Chen Li, Yudong Yao, Wei Qian, Yubao Guan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.598721/full |
Similar Items
-
Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma
by: Duo Hong, et al.
Published: (2020-01-01) -
CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
by: Dongdong Mei, et al.
Published: (2018-12-01) -
Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01) -
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
by: Wang Wen-Ping, et al.
Published: (2012-01-01) -
Segmentation of lung parenchyma in CT images using CNN trained with the clustering algorithm generated dataset
by: Mingjie Xu, et al.
Published: (2019-01-01)